A Curated Platform of Equity & Options Market Intelligence
Select Page

MGNX

Search by
TICKER SYMBOL

Macrogenics Inc

Sector: Manufacturing
Industry: Pharmaceutical Products

1.71

-0.08

(-4.47%)

Volume:

837,467

52 week range:

0.99 - 16.44

Market Cap:

107.884M

Company Description:

MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer. The company also develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4.